title: [Use of recombinant hematopoietic growth factors after chemotherapy and high-dose chemo-radiotherapy].
authors.forename: A M
authors.initials: AM
authors.lastname: Gianni
authors.forename: M
authors.initials: M
authors.lastname: Bregni
authors.forename: S
authors.initials: S
authors.lastname: Siena
authors.forename: C
authors.initials: C
authors.lastname: Tarella
mesh_terms: D000741:Anemia, Aplastic / Q000188:drug therapy* / Q000209:etiology; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D003131:Combined Modality Therapy / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D003561:Cytarabine / Q000009:adverse effects; D004341:Drug Evaluation; D005047:Etoposide / Q000009:adverse effects; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007938:Leukemia / Q000150:complications / Q000628:therapy; D008558:Melphalan / Q000009:adverse effects; D009369:Neoplasms / Q000150:complications / Q000628:therapy; D011878:Radiotherapy / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D003115:Colony-Stimulating Factors; D003561:Cytarabine; D005047:Etoposide; D003520:Cyclophosphamide; D008558:Melphalan
vernacular_title: Impiego di fattori di crescita emopoietici ricombinanti dopo chemioterapia e chemioradioterapia ad alte dosi.